The Purpose of this study is to see if it is possible to deliver an intervention that targets trauma, substance use, and engagement in HIV care with HIV-positive women.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
16
Clinical Research Building
Miami, Florida, United States
Reduction in HIV RNA Copies/mL
Time frame: 6 months
Increase in T-helper (CD4+) cell count
Time frame: 6 months
Reduction in HIV transmission risk
self-reported condomless, serodiscordant sex and HIV viral load greater than 200 copies/mL
Time frame: 6 months
Decrease in stimulant use
self-report
Time frame: 6 months
Decrease in stimulant use
urine toxicology screening
Time frame: 6 months
Decrease in post-traumatic stress disorder (PTSD) symptoms
self-report measure: PTSD Checklist for DSM-5
Time frame: 6 months
Decrease in depressive symptoms
self-report measure: Centers for the Epidemiologic Study of Depression (CES-D)
Time frame: 6 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.